Susquehanna International Group
ACET icon

Susquehanna International Group’s Adicet Bio ACET Stock Holding History

Susquehanna International Group’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-663
Closed -$10.2K – 12366
2024
Q4 		$10.2K Buy
+663
New +$12.5K ﹤0.01% 11983
2024
Q3 		– Sell
-1,531
Closed -$29.6K – 11853
2024
Q2 		$29.6K Buy
1,531
+387
+34% +$10.4K ﹤0.01% 11571
2024
Q1 		$43K Buy
+1,144
New +$47.3K ﹤0.01% 11612
2023
Q3 		– Sell
-669
Closed -$26K – 11918
2023
Q2 		$26K Sell
669
-12
-2% -$1.06K ﹤0.01% 11566
2023
Q1 		$62.8K Buy
+681
New +$85.5K ﹤0.01% 11589
2022
Q4 		– Sell
-5,175
Closed -$1.18M – 12257
2022
Q3 		$1.18M Buy
5,175
+3,525
+214% +$895K ﹤0.01% 6217
2022
Q2 		$385K Buy
1,650
+87
+6% +$19.1K ﹤0.01% 8887
2022
Q1 		$499K Sell
1,563
-3,406
-69% -$783K ﹤0.01% 8976
2021
Q4 		$1.39M Buy
+4,969
New +$853K ﹤0.01% 6406
2020
Q2 		– Sell
-340
Closed -$39K – 10028
2020
Q1 		$39K Buy
340
+234
+221% +$34.7K ﹤0.01% 9761
2019
Q4 		$18K Buy
+106
New +$53.7K ﹤0.01% 9496

Other funds holding ACET

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Susquehanna International Group's ACET Position: Q4 2025 in Review

Susquehanna International Group sold out of Adicet Bio (ACET) in Q4 2025, closing a stake of 2,523 shares — an estimated $32.7K sold.

Susquehanna International Group first reported a position in ACET in Q4 2019 and held it in 20 quarters. The position peaked at $1.13M in Q1 2021. 49 funds tracked by Wall St. Rank hold ACET as of Q4 2025.

  • Susquehanna International Group reported no remaining Adicet Bio position as of Q4 2025 after selling out during the quarter.
  • Susquehanna International Group sold 2,523 Adicet Bio shares in Q4 2025, an estimated $32.7K.
  • Susquehanna International Group first reported a position in Adicet Bio in Q4 2019 and held it in 20 quarters.
  • Susquehanna International Group's Adicet Bio position peaked at $1.13M in Q1 2021.
  • 49 funds tracked by Wall St. Rank held Adicet Bio as of Q4 2025.

Based on Susquehanna International Group's 13F filing for Q4 2025, filed 17 Feb 2026.